[Federal Register Volume 84, Number 250 (Tuesday, December 31, 2019)]
[Notices]
[Pages 72367-72368]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-28249]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket Nos. FDA-2013-N-0134; FDA-2011-N-0902; FDA-2013-N-0662; FDA-
2013-N-0242; FDA-2019-N-1517; FDA-2019-N-0549; FDA-2019-N-0305; FDA-
2012-N-0477; FDA-2016-D-2565, and FDA-2018-N-4839]


Agency Information Collection Activities; Announcement of Office 
of Management and Budget Approvals

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is publishing a list of 
information collections that have been approved by the Office of 
Management and Budget (OMB) under the Paperwork Reduction Act of 1995.

FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, Office of Operations, 
Food and Drug Administration, Three White Flint North, 10A-12M, 11601 
Landsdown St., North Bethesda, MD 20852, 301-796-7726, 
[email protected].

SUPPLEMENTARY INFORMATION: The following is a list of FDA information 
collections recently approved by OMB under section 3507 of the 
Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control 
number and expiration date of OMB approval for each information 
collection are shown in table 1. Copies of the supporting statements 
for the information collections are available on the internet at http://www.reginfo.gov/public/do/PRAMain. An Agency may not conduct or 
sponsor, and a person is not required to respond to, a collection of 
information unless it displays a currently valid OMB control number.

        Table 1--List of Information Collections Approved by OMB
------------------------------------------------------------------------
                                            OMB control    Date approval
           Title of collection                  No.           expires
------------------------------------------------------------------------
Mammography Quality Standards Act              0910-0309      10/31/2022
 Requirements...........................
Prescription Drug Product Labeling;            0910-0393      10/31/2022
 Medication Guide Requirements..........
Applications for FDA Approval to Market        0910-0513      10/31/2022
 a New Drug: Patent Submission and
 Listing Requirements and Application of
 30-month Stays on Approval of
 Abbreviated New Drug Applications
 Certifying That a Patent Claiming a
 Drug Is Invalid or Will Not Be
 Infringed..............................
Current Good Manufacturing Practice for        0910-0667      10/31/2022
 Positron Emission......................

[[Page 72368]]

 
Abbreviated New Animal Drug Applications       0910-0669      10/31/2022
Medical Devices: Use of Certain Symbols        0910-0740      10/31/2022
 in Labeling--Glossary to Support the
 Use of Symbols in Labeling.............
Deeming Tobacco Products to be Subject         0910-0768      10/31/2022
 to the Federal Food, Drug, and Cosmetic
 Act....................................
Investigational Device Exemptions              0910-0078      11/30/2022
 Reports and Records....................
510(k) Third-Party Review Program.......       0910-0375      11/30/2022
Guidance for Industry With the Center          0910-0454      11/30/2022
 for Veterinary Medicine's Electronic
 Submission System......................
------------------------------------------------------------------------


    Dated: December 16, 2019.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2019-28249 Filed 12-30-19; 8:45 am]
 BILLING CODE 4164-01-P